newsfilter
← Latest News
GlobeNewswire·

Axsome Therapeutics to Report Second Quarter 2026 Financial Results on August 10

NEW YORK, July 14, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced it will